Abstract
The i.v. and i.m. dose pharmacokinetics of ceftazidime 1 g b.i.d. were investigated in steady state in 52 consecutive cases of hospitalised patients with underlying diseases and serious supervening bacterial infections. Following i.v. bolus injection, serum concentrations of >4 mg/l persisted for 8 h in all patients. Compared to values found in younger patients studied previously, clearance was markedly reduced in the elderly, t1/2β more than doubled, the area under the curve four times enlarged and the apparent volume of distribution reduced. The values obtained in serum after i.m. injection were similar, though the peak concentration was delayed by about 2 h. The serum uptake was approximately 70 %, and serum concentration was >4 mg/l for 8 h. The concentrations in tissue fluid after i.v. administration were similar to those in serum, but the penetration into tissue fluid was slower and only 20 % of that reported previously for young people. The elimination was slow, with >4 mg/l maintained for 7 h. Tissue concentrations after i.m. injection were almost comparable with those after i.v. injection, but lagged behind by about 1 h. In conclusion, suitable concentrations in blood and tissue are attained with 1 g ceftazidime b.i.d., whether administered by the i.v. or i.m. route.
Similar content being viewed by others
References
O'Callaghan CH, Acred P, Harper PB, Ryan DM, Kirby SM, Harding SM GR 20263, a new broad-spectrum cephalosporin with pseudomonal activity. Antimicrobial Agents and Chemotherapy 1980, 17: 876–883.
Harding SM, Ayrton J, Thornton JE, Munroe AJ, Hogg MIJ Pharmacokinetics of ceftazidime in normal subjects. Journal of Antimicrobial Chemotherapy 1981, 8, Supplement B: 261–262.
Wise R, Armstrong GC, Brown RM, Andrews JM The pharmacokinetics and tissue penetration of ceftazidime and cefamandole in healthy volunteers. Journal of Antimicrobial Chemotherapy 1981, 8, Supplement B: 277–282.
Leroy A, Leguy F, Borsa F, Spencer GR, Fillastre JP, Humbert G Pharmacokinetics of ceftazidime in normal and uremic subjects. Journal of Antimicrobial Chemotherapy 1984, 25: 638–642.
Ryan DM, Mason U, Harding SM The penetration of ceftazidime into extravascular fluid. Journal of Antimicrobial Chemotherapy 1981, 8, Supplement B: 283–288.
Ryan DM, Cars O A problem in interpretation of beta-lactam antibiotic levels in tissues. Journal of Antimicrobial Chemotherapy 1983, 12: 281–284.
Höffler D, Koeppe P, Williams KJ The pharmacokinetics of ceftazidime in normal and impaired renal function. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement A: 241–245.
Hoffstedt B, Walder M Penetration of ceftazidime into extracellular fluid in patients. Journal of Antimicrobial Chemotherapy 1981, 8, Supplement B: 289–292.
Gibaldi M, Perrier D Pharmacokinetics. Marcel Dekker, New York, 1985.
Naber KG, Kees F, Grobecker H Ceftazidime: pharmacokinetics in young volunteers vs. elderly patients and therapeutic efficacy with complicated urinary tract infections. Journal of Antimicrobial Chemotherapy 1983, 12, Supplement A: 41–45.
Ljungberg B, Nilsson-Ehle I Influence of age on the pharmacokinetics of ceftazidime in acutely ill, adult patients. European Journal of Clinical Pharmacology 1988, 34: 173–178.
Ljungberg B, Nilsson-Ehle I Comparative pharmacokinetics of ceftazidime in young, healthy and elderly, acutely ill males. European Journal of Clinical Pharmacology 1988, 34: 179–186.
Bergan T Pharmacokinetics of tissue penetration of antibiotics. Reviews of Infectious Diseases 1981, 3: 45–66.
Cockcroft DW, Gault MH Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16: 31–41.
Gundersen J Segmental measurements of systolic blood pressure in the extremities including the thumb and great toe. Acta Chirurgica Scandinavica 1972, 426: 1–48.
Hoffstedt B, Walder M Penetration of ampicillin, doxycycline and gentamicin into interstitial fluid in rabbits and of penicillin V and pivampicillin in humans measured with subcutaneously implanted cotton threads. Infection 1981, 9: 7–11.
Hoffstedt B, Walder M, Forsgren A Comparison of skin blisters and implanted cotton threads for the evaluation of antibiotic tissue concentrations. European Journal of Clinical Microbiology 1982, 1: 33–37.
Harding SM, Harper PB The pharmacokinetic behaviour of ceftazidime in man and the relationship between serum levels and the in vivo susceptibility of clinical isolates. Infection 1983, 11, Supplement 1: 49–53.
Welage LS, Schultz RW, Schentag JJ Pharmacokinetics of ceftazidime in patients with renal insufficiency. Antimicrobial Agents and Chemotherapy 1984, 25: 201–204.
Douglas JG, Bax RP, Munroe JF The pharmacokinetics of cefuroxime in the elderly. Journal of Antimicrobial Chemotherapy 1980, 6: 543–549.
Schmidt H, Roholt K Penicillin serum concentrations in relation to exercise. Acta Pathologica et Microbiologica Scandinavica 1966, 68: 396–400.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jonsson, M., Walder, M. Pharmacokinetics of ceftazidime in acutely Ill hospitalised elderly patients. Eur. J. Clin. Microbiol. Infect. Dis. 11, 15–21 (1992). https://doi.org/10.1007/BF01971265
Issue Date:
DOI: https://doi.org/10.1007/BF01971265